China Pharma Holdings, Inc. (CPHI) KPIs and segments
Close on Nov 11, 2026Market cap $23.37MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive China Pharma's business
China Pharma's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
Domestic Pharmaceuticals($M) | 2.89 | 1.98 | 2.42 | 2.90 | 2.40 | 2.07 | 3.05 | 2.38 | 2.57 | |
Export Medical Test Kits($M) | 0.03 | 0 | 1.70 | |||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2022-03-30.
See a number that looks wrong?